Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment recommendations for anaplastic oligodendrogliomas that are codeleted.

Oncology (Williston Park, N.Y.) - 1 Apr 2013

Anderson Mark D, Gilbert Mark R

Abstract excerpt

Abstract: Anaplastic oligodendroglioma (AO) is a rare malignant tumor occurring in adults. Despite early indications of chemosensitivity, no clinical trial had demonstrated a benefit of chemotherapy beyond that of radiotherapy alone. Now, however, the Radiation Therapy Oncology Group (RTOG) 9402 and the European Organisation for Research and Treatment of Cancer (EORTC) 26951 studies investigating PCV...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Dacarbazine
Share to Isocitrate Dehydrogenase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Oligodendroglioma

Share to Temozolomide

Source

Identifiers

PMID: 23781695

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment recommendations for anaplastic oligodendrogliomas that are codeleted.PMID 23781695Read ↗

Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide.Semantic proximity Read ↗

Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy.Semantic proximity Read ↗

Anaplastic glioma: current treatment and management.Semantic proximity Read ↗

Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.Semantic proximity Read ↗

Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH.Semantic proximity Read ↗

Treatment of oligodendroglioma: an update.Semantic proximity Read ↗

[Oligodendroglioma, IDH Mutation and 1p/19q Codeletion].Semantic proximity Read ↗

Survival outcome and prognostic factors in anaplastic oligodendroglioma: a single-institution study of 95 cases.Semantic proximity Read ↗

Low-grade and anaplastic oligodendroglioma.Semantic proximity Read ↗

Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic OligodendrogliomasSemantic proximity Read ↗

Genetic landscape of extreme responders with anaplastic oligodendroglioma.Semantic proximity Read ↗

Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.